Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia
Alhomidi Almotiri, … , Florian A. Siebzehnrubl, Neil P. Rodrigues
Alhomidi Almotiri, … , Florian A. Siebzehnrubl, Neil P. Rodrigues
Published October 27, 2020
Citation Information: J Clin Invest. 2021;131(1):e129115. https://doi.org/10.1172/JCI129115.
View: Text | PDF
Research Article Hematology Article has an altmetric score of 38

Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia

  • Text
  • PDF
Abstract

Zeb1, a zinc finger E-box binding homeobox epithelial-mesenchymal transition (EMT) transcription factor, confers properties of “stemness,” such as self-renewal, in cancer. Yet little is known about the function of Zeb1 in adult stem cells. Here, we used the hematopoietic system as a well-established paradigm of stem cell biology to evaluate Zeb1-mediated regulation of adult stem cells. We employed a conditional genetic approach using the Mx1-Cre system to specifically knock out (KO) Zeb1 in adult hematopoietic stem cells (HSCs) and their downstream progeny. Acute genetic deletion of Zeb1 led to rapid-onset thymic atrophy and apoptosis-driven loss of thymocytes and T cells. A profound cell-autonomous self-renewal defect and multilineage differentiation block were observed in Zeb1-KO HSCs. Loss of Zeb1 in HSCs activated transcriptional programs of deregulated HSC maintenance and multilineage differentiation genes and of cell polarity consisting of cytoskeleton-, lipid metabolism/lipid membrane–, and cell adhesion–related genes. Notably, epithelial cell adhesion molecule (EpCAM) expression was prodigiously upregulated in Zeb1-KO HSCs, which correlated with enhanced cell survival, diminished mitochondrial metabolism, ribosome biogenesis, and differentiation capacity and an activated transcriptomic signature associated with acute myeloid leukemia (AML) signaling. ZEB1 expression was downregulated in AML patients, and Zeb1 KO in the malignant counterparts of HSCs — leukemic stem cells (LSCs) — accelerated MLL-AF9– and Meis1a/Hoxa9-driven AML progression, implicating Zeb1 as a tumor suppressor in AML LSCs. Thus, Zeb1 acts as a transcriptional regulator in hematopoiesis, critically coordinating HSC self-renewal, apoptotic, and multilineage differentiation fates required to suppress leukemic potential in AML.

Authors

Alhomidi Almotiri, Hamed Alzahrani, Juan Bautista Menendez-Gonzalez, Ali Abdelfattah, Badi Alotaibi, Lubaid Saleh, Adelle Greene, Mia Georgiou, Alex Gibbs, Amani Alsayari, Sarab Taha, Leigh-anne Thomas, Dhruv Shah, Sarah Edkins, Peter Giles, Marc P. Stemmler, Simone Brabletz, Thomas Brabletz, Ashleigh S. Boyd, Florian A. Siebzehnrubl, Neil P. Rodrigues

×

Total citations by year

Year: 2025 2024 2023 2022 2021 Total
Citations: 3 8 14 10 3 38
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (38)

Title and authors Publication Year
Exploring the Role of Epithelial–Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review
Kanwal R, Esposito JE, Jawed B, Zakir SK, Pulcini R, Martinotti R, Botteghi M, Gaudio F, Martinotti S, Toniato E
Cancers 2025
Dualistic role of ZEB1 and ZEB2 in tumor progression
Parfenyev SE, Daks AA, Shuvalov OY, Fedorova OA, Pestov NB, Korneenko TV, Barlev NA
Biology Direct 2025
Transcriptomic characterisation of acute myeloid leukemia cell lines bearing the same t(9;11) driver mutation reveals different molecular signatures
Georges E, Ho W, Iturritza MU, Eory L, Malysz K, Sobhiafshar U, Archibald AL, Macqueen DJ, Shih B, Garrick D, Vernimmen D
BMC Genomics 2025
The landscape of SETBP1 gene expression and transcription factor activity across human tissues.
Whitlock JH, Wilk EJ, Howton TC, Clark AD, Lasseigne BN
PloS one 2024
Twist family BHLH transcription factor 1 is required for the maintenance of leukemia stem cell in MLL-AF9(+) acute myeloid leukemia.
Wang N, Yin J, You N, Zhu W, Guo N, Liu X, Zhang P, Huang W, Xie Y, Ren Q, Ma X
Haematologica 2024
Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
Zhou J, Lan F, Liu M, Wang F, Ning X, Yang H, Sun H
Frontiers in pharmacology 2024
Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
Velasco\u2010Hernandez T, Trincado JL, Vinyoles M, Closa A, Martínez\u2010Moreno A, Gutiérrez\u2010Agüera F, Molina O, Rodríguez\u2010Cortez VC, Ximeno\u2010Parpal P, Fernández\u2010Fuentes N, Petazzi P, Beneyto\u2010Calabuig S, Velten L, Romecin P, Casquero R, Abollo\u2010Jiménez F, de la Guardia RD, Lorden P, Bataller A, Lapillonne H, Stam RW, Vives S, Torrebadell M, Fuster JL, Bueno C, Sarry J, Eyras E, Heyn H, Menéndez P
HemaSphere 2024
Conditional deletion of Zeb1 in Csf1r+ cells reduces inflammatory response of the cornea to alkali burn
Do KK, Wang F, Sun X, Zhang Y, Liang W, Liu JY, Jiang DY, Lu X, Wang W, Zhang L, Dean DC, Liu Y
iScience 2024
Corneal injury repair and the potential involvement of ZEB1.
Jin L, Zhang L, Yan C, Liu M, Dean DC, Liu Y
2024
The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression
Cuevas D, Amigo R, Agurto A, Heredia AA, Guzmán C, Recabal-Beyer A, González-Pecchi V, Caprile T, Haigh JJ, Farkas C
Biomedicines 2024
ZEB1 Inhibits LHβ Subunit Transcription When Overexpressed, but Is Dispensable for LH Synthesis in Mice
Schultz H, Zhou X, Alonso CA, Ongaro L, Lin YF, Loka M, Brabletz T, Brabletz S, Stemmler MP, Boehm U, Bernard DJ
Endocrinology 2024
Ploidy-stratified single cardiomyocyte transcriptomics map Zinc Finger E-Box Binding Homeobox 1 to underly cardiomyocyte proliferation before birth
Bak ST, Harvald EB, Ellman DG, Mathiesen SB, Chen T, Fang S, Andersen KS, Fenger CD, Burton M, Thomassen M, Andersen DC
Basic Research in Cardiology 2023
RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification
Li R, Wu X, Xue K, Feng D, Li J, Li J
Biomarker Research 2023
Single-cell resolution reveals RalA GTPase expanding hematopoietic stem cells and facilitating of BCR-ABL1-driven leukemogenesis in a CRISPR/Cas9 gene editing mouse model
Yin Z, Su R, Ge L, Wang X, Yang J, Huang G, Li C, Liu Y, Zhang K, Deng L, Fei J
International journal of biological sciences 2023
A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling
Zhu L, Tang Y, Li X, Kerk SA, Lyssiotis CA, Feng W, Sun X, Hespe GE, Wang Z, Stemmler MP, Brabletz S, Brabletz T, Keller ET, Ma J, Cho J, Yang J, Weiss SJ
The EMBO Journal 2023
E3 ubiquitin ligase on the biological properties of hematopoietic stem cell.
Zhan Q, Wang J, Zhang H, Zhang L
Journal of Molecular Medicine 2023
Exosomal ZEB1 Derived from Neural Stem Cells Reduces Inflammation Injury in OGD/R-Treated Microglia via the GPR30-TLR4-NF-κB Axis.
Peng J, Yu Z, Xiao R, Hu X, Xia Y
Neurochemical Research 2023
IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia
Wu S, Chi C, Weng S, Zhou W, Liu Z
Apoptosis : an international journal on programmed cell death 2023
Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
Khademi R, Malekzadeh H, Bahrami S, Saki N, Khademi R, Villa-Diaz LG
Cancers 2023
An "unexpected" role for EMT transcription factors in hematological development and malignancy
Radhakrishnan K, Truong L, Carmichael CL
Frontiers in immunology 2023
Zeb1 Regulates the Function of Lympho-Myeloid Primed Progenitors after Transplantation
Almotiri A, Boyd AS, Rodrigues NP
Biomolecules 2023
The landscape of SETBP1 gene expression and transcription factor activity across human tissues
Whitlock JH, Wilk EJ, Howton TC, Clark AD, Lasseigne BN
2023
Isolation of tumor stem-like cells from primary laryngeal squamous cell carcinoma cells (FD-LS-6).
Zhang D, Tang D, Liu PT, Tao L, Lu LM
Human Cell 2023
A Vaccine against Cancer: Can There Be a Possible Strategy to Face the Challenge? Possible Targets and Paradoxical Effects
Zefferino R, Conese M
Human vaccines 2023
Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1.
Trsova I, Hrustincova A, Krejcik Z, Kundrat D, Holoubek A, Staflova K, Janstova L, Vanikova S, Szikszai K, Klema J, Rysavy P, Belickova M, Kaisrlikova M, Vesela J, Cermak J, Jonasova A, Dostal J, Fric J, Musil J, Dostalova Merkerova M
Molecular Oncology 2023
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
Z Huang, Z Zhang, C Zhou, L Liu, C Huang
2022
Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer
J Zhang, Q Li, Q Sun, B Wang, Y Cui, C Lou, Y Yao, Y Zhang
Journal of Cancer 2022
Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes
M Merkerova, J Klema, D Kundrat, K Szikszai, Z Krejcik, A Hrustincova, I Trsova, A Le, J Cermak, A Jonasova, M Belickova
Cancer genomics & proteomics 2022
Expression of Zeb1 in the differentiation of mouse embryonic stem cell
Chen T, Pan P, Wei W, Zhang Y, Cui G, Yu Z, Guo X
Open Life Sciences 2022
The Role of NOTCH1, GATA3, and c-MYC in T Cell Non-Hodgkin Lymphomas
Al-Khreisat MJ, Hussain FA, Abdelfattah AM, Almotiri A, Al-Sanabra OM, Johan MF
Cancers 2022
Zeb1 sustains hematopoietic stem cell functions by suppressing mitofusin-2-mediated mitochondrial fusion
Zhang K, Zhao H, Sheng Y, Chen X, Xu P, Wang J, Ji Z, He Y, Gao WQ, Zhu HH
Cell Death and Disease 2022
Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia
Wang W, Liang Q, Zhao J, Pan H, Gao Z, Fang L, Zhou Y, Shi J
Frontiers in Genetics 2022
The role of the ZEB1–neuroinflammation axis in CNS disorders
Poonaki E, Kahlert UD, Meuth SG, Gorji A
Journal of Neuroinflammation 2022
Hsa_circ_0005529 promotes ZEB1 expression by regulating miR-873-5p and enhancing proliferation, invasion, and migration in gastric cancer cell lines.
Su X, Zhou R, Wu Y, Zhang Y, Yu Y, Lu M
Journal of Clinical Laboratory Analysis 2022
Limb expression 1-like protein promotes epithelial-mesenchymal transition and epidermal growth factor receptor-tyrosine kinase inhibitor resistance via nucleolin-mediated ribosomal RNA synthesis in non-small cell lung cancer.
Li M, Zhang J, Meng X, Liu B, Xie SM, Liu F, Yao D, Zhang J, Shen H, Xing L
Cancer Science 2022
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape
E Chiarella, A Aloisio, S Scicchitano, K Todoerti, EG Cosentino, D Lico, A Neri, N Amodio, HM Bond, M Mesuraca
International journal of molecular sciences 2021
Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity
J Wang, C Farkas, A Benyoucef, C Carmichael, K Haigh, N Wong, D Huylebroeck, MP Stemmler, S Brabletz, T Brabletz, CM Nefzger, S Goossens, G Berx, JM Polo, JJ Haigh, CJ Eaves
PLoS Biology 2021
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells
Q Wang, YT Yen, C Xie, F Liu, Q Liu, J Wei, L Yu, L Wang, F Meng, R Li, B Liu
Drug Delivery 2021

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 51 X users
37 readers on Mendeley
See more details